Parkinson’s Drug Candidate Enhances Levodopa Therapy While Reducing Side Effects

New drug candidate improves Parkinson's treatment in animal models

For many people with Parkinson's disease, the body stops moving the way it used to. A hand may tremble at rest. Muscles may stiffen.

Parkinson’s Drug Candidate Enhances Levodopa Therapy While Reducing Side Effects

Scientists have identified a compound that could improve the benefits of levodopa treatment for patients with Parkinson’s disease while delaying or preventing side effects that commonly develop with long-term use. The discovery was made at Sinopia Biosciences, a spinout of the University of California San Diego that analyzes large biological datasets to identify novel therapeutic approaches for preventing and managing side effects of existing dr…

Drug candidate could help L-dopa work better for patients with Parkinson's

For many people with Parkinson's disease, the body stops moving the way it used to. A hand may tremble at rest. Muscles may stiffen. Walking can become slower and balance more uncertain. The most effective treatment remains L-dopa, also called levodopa, a medication that can dramatically improve movement and quality of life. But the relief often comes with a caveat: Over time, the drug's benefits can become less reliable, and it can cause erratic, involuntary movements known as dyskinesia.

Drug candidate may improve L-dopa effectiveness for Parkinson’s patients

For many people living with Parkinson’s disease, levodopa (L-dopa) remains the most effective therapy for restoring movement. Yet long-term treatment often brings two major problems: motor fluctuations, in which symptoms return between doses, and dyskinesia, involuntary movements that can erode quality of life. The clinical challenge is that physicians typically cannot add a single, robust […]